Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Bullboard Posts
Post by ledzep4uon Dec 25, 2018 2:39pm
160 Views
Post# 29156630

Canopy and Battelle and ebbu

Canopy and Battelle and ebbuI've been thinking about the potential of the Battelle partnership and it was peaked when Bruce mentioned on his last Midas Letter interview that they have 12,000 employees world wide. If you go on their website, it's quite an amazing organization:

https://www.battelle.org/

I re-read the announcement on Nov. 27 below:

https://www.canopygrowth.com/wp-content/uploads/2018/11/Canopy-Battelle-collaboration-release-FINAL-EN.pdf

I then went looking for some info on Battelle around the same time and found the article below:

https://www.bizjournals.com/columbus/news/2018/11/27/battelle-imports-marijuana-for-central-ohio.html

In particular, I found the following from the article very interesting (underlining is mine)

Companies selling marijuana for medical purposes have faced a conundrum: Because of the federal ban on the product, there's almost no U.S. clinical research to back up largely anecdotal evidence of marijuana's benefits, such as restoring appetite for cancer patients or reducing pain and inflammation.

The Battelle/ebbu partnership with Canopy now makes great sense. If you now go to ebbu's website and read about their patents/inventions and delivery systems:

https://www.ebbu.com/science-ebbu/

I now believe that all the ducks are in a row to be the first to get FDA approval for CBD infused drinks quickly (then there's Constellation for manufacturing/bottling/marketing/distribution). Now add ointments/topicals/oral oils, etc. to the mix. 

Bullboard Posts